More than a third of adults in China suffer from high blood pressure, but only one in 20 are able effectively to manage their condition, according to research published on Thursday, the South China Morning Post reports. Strokes are the leading cause of death in China, accounting for one in five deaths annually, researchers said, […]
Category: Health Care
China will allow the use of data from overseas clinical trials for approvals of new drugs, in a move likely to enable multinationals to bring products to the world’s second-largest pharmaceutical market more quickly, the Financial Times reports. Pharmaceutical approvals in China can take up to seven years longer than in Europe and the US […]
A unit of China’s Fosun Group has agreed to acquire 74% of Indian drug company Gland Pharma for $1.1 billion, resurrecting a deal that was previously blocked by the Indian government, The Wall Street Journal reports. Shanghai Fosun Pharmaceutical said it is planning to buy 74% of Gland Pharma, a Hyderabad-based company that makes generic injectable […]
Caixin reports Chinese biotech drug developer 3SBio Inc. said it will expand to North America by acquiring Canadian assets, marking the latest move by a Chinese drugmaker into the global market. The $290-million deal will see 3SBio take over the contract development and manufacturing (CDMO) business of Ontario-based Therapure Biopharma, 3SBio said in a filing […]
Zai Lab Ltd., a Chinese drug developer working on cancer treatments, has picked banks to arrange a planned US initial public offering that could raise about $150 million, people with knowledge told Bloomberg. The Shanghai-based biopharmaceutical company, started by former Pfizer senior scientist Samantha Du, is working with Citigroup and JPMorgan Chase & Co., according to the people. It is targeting […]